A Multisite Trial of ACQUIREc Therapy

Completed · Not applicable

Conditions studied: Hemiparetic Cerebral Palsy

In brief

A multisite trial to testing different dosage levels of a systematic form of Pediatric Constraint-Induced (CI) Therapy called ACQUIREc Therapy. The high dosage treatment involved 6 hours of daily therapy services for 21 days. This was compared to a moderate dosage level of 3 hours of daily therapy services for 21 days. It was hypothesized that children receiving the higher therapy dosage would have greater and more clinically significant benefits from ACQUIREc Therapy but that both groups of children would benefit from the therapy services.

Key facts

Study ID

NCT00991692

Run by

University of Alabama at Birmingham

People needed

18

Starts

2008-06-01

Expected to finish

2009-10-01

Last updated by the study team

2009-10-08

Who can join

Age: 3 and older, up to 8. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children 3-6 years of age
• Hemiparetic CP

You may not qualify if…

• No prior CI therapy treatments
• No Botox for 6-months

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.